Temporal tuning of daily rhythms helps advanced cancer patients and cancer survivors feel better, live better, and live longer

References

• Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013;3:120144.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz LK Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546–1558.
   PubMed Web of Science ®Google Scholar
• Blau C, Liakopoulou E. Can we deconstruct cancer, one patient at a time? Trends Genet. 2013;29(1):6–10.
   PubMed Web of Science ®Google Scholar
• Haber D, Gray N, Baselga J. The evolving war on cancer. Cell. 2011;145(1):19–24.
   PubMed Web of Science ®Google Scholar
• Bozic I, Allen B, Nowak M. Dynamics of targeted cancer therapy. Trends Mol Med. 2012;18(6):311–316.
   Web of Science ®Google Scholar
• Joyner MJ, Prendergast FG. Chasing Mendel: five questions for personalized medicine. J Physiol. 2014;592:2381–2388.
   Web of Science ®Google Scholar
• Greaves M. Cancer; The Evolutionary Legacy. New York, NY: Oxford University Press; 2000:276.
   Google Scholar
• Wagner A. The molecular origins of evolutionary innovations. Trends Genet. 2011;27(10):397–410.
   Web of Science ®Google Scholar
• Joyner MP. Chasing Mendel: five questions for personalized medicine. J Physiol. 2014;592:2381–2388.
   Web of Science ®Google Scholar
• Foster R, Wulff K. The rhythm of rest and excess. Nat Rev Neurosci. 2005;6:407–414.
   PubMed Web of Science ®Google Scholar
• Haimov I, Lavie P. Melatonin a chronobiotic and soporific hormone. Arch Gerontol Geriatr. 1997;24:167–173.
   PubMed Web of Science ®Google Scholar
• Hunter P. To sleep, perchance to live, Sleeping is vital for health, cognitive function, memory and long life. EMBO Rep. 2008;9:1070–1073.
   Web of Science ®Google Scholar
• Froy O. The circadian clock and metabolism. Clin Sci. 2011;120:65–72.
   PubMed Web of Science ®Google Scholar
• Rabstein S, Harth V, Justenhoven C, et al. Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study. Chronobiol Int. 2014;17:1–8.
   Google Scholar
• Shanmugam V, Wafi A, ‘al-Taweel N, Busselberg D. Disruption of circadian rhythm increases the risk of cancer, metabolic syndrome and cardiovascular disease. J Local Global Health Sci. 2013;209:3.
   Google Scholar
• Sancar A, Lindsey-Boltz L, Gaddameedhi S, et al. Circadian clock, cancer, and chemotherapy. Biochemistry. Epub October 29, 2014.
   Google Scholar
• Filipski E, et al. Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris). 2003;51:216–219.
   PubMed Web of Science ®Google Scholar
• Davis S, Mirick D, Stevens R. Night-shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93:1557–1562.
   PubMed Web of Science ®Google Scholar
• Rondanelli M, Faliva MA, Perna S, Antoniello N. Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks. Aging Clin Exp Res. 2013;25:499–510. doi:10.1007/s4050-013-0118-6.
   PubMed Web of Science ®Google Scholar
• Wood P, Yang X, Taber A, et al. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 2008;6:1786–1793.
   PubMed Web of Science ®Google Scholar
• Zhao X, Cho H, Yu R, Atkins A, Downes M, Evans R. Nuclear receptors rock around the clock. EMBO Rep. 2014;15:518–528.
   PubMed Web of Science ®Google Scholar
• Yang X, Wood P, Oh E-Y, Du-Quiton J, Ansell C, Hrushesky W. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009;117:423–431.
   PubMed Web of Science ®Google Scholar
• Yang W, Stockwell B. Inhibition of casein kinase I-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol. 2008;9:R92.
   PubMed Web of Science ®Google Scholar
• Van der Zee E, Havekes R, Barf RP, et al. Circadian time-place learning in mice depends on cry genes. Curr Biol. 2008;18:844–848.
   PubMed Web of Science ®Google Scholar
• Wyse C, Coogan A, Selman C, Hazlerigg D, Speakman JR. Association between mammalian lifespan and circadian free-running period: the circadian resonance hypothesis revisited. Biol Lett. 2010;6:696–698.
   PubMed Web of Science ®Google Scholar
• Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005;9:11–24.
   PubMed Web of Science ®Google Scholar
• Savvidis CK. Circadian rhythm disruption in cancer biology. Mol Med. 2012;18:1249–1260.
   PubMed Web of Science ®Google Scholar
• Fonken L, Nelson R. Illuminating the deleterious effects of light at night. F1000 Med Rep. 2011;3:18. doi:10.3410/M3-18.
   PubMedGoogle Scholar
• Reiter R, Tan D, Korkmaz A, et al. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit Rev Oncog. 2007;13:303–328.
   PubMedGoogle Scholar
• Bhatti P, Mirick D, Davis S. Shift work and cancer. Am J Epidemiol. 2012;45:760–763.
   Google Scholar
• Blask D, Dauchy R, Sauer L, Krause J, Brainard J. Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett. 2002;22(Suppl 2):52–56.
   Google Scholar
• Blask D, Brainard G, Dauchy R, et al. Melatonin depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 2005;65:11174–11184.
   PubMed Web of Science ®Google Scholar
• Dauchy R, Xiang S, Mao L, et al. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res. 2014;74:1–12.
   Web of Science ®Google Scholar
• Blask DE, Hill SM, Dauchy RT, et al. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res. 2011;51(3):259–269.
   PubMed Web of Science ®Google Scholar
• Berger A, Hertzog M, Geary C, Fischer P, Farr L. Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. J Cancer Surviv. 2012;6:305–314.
   PubMed Web of Science ®Google Scholar
• Innominato P, Focan F, Gorlia T, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 2009;69:4700–4707.
   PubMed Web of Science ®Google Scholar
• Grutsch J, Wood P, Du-Quiton J, et al. Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhythms. 2011;9:4.
   PubMedGoogle Scholar
• Ohayon M, Carskadon M, Guilleminault CV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27:1255–1273.
   PubMed Web of Science ®Google Scholar
• Buysse D, Reynolds CI, Monk T, Berman S, Kupfer D. The Pittsburgh Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
   PubMed Web of Science ®Google Scholar
• Littner M, Kushida C, Anderson W, et al. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep. 2003;26:337–341.
   PubMed Web of Science ®Google Scholar
• McClung C. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. 2007;114:222–232.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A. Temporal organization as a therapeutic target. Dialogues Clin Neurosci. 2012;14:335–337.
   PubMedGoogle Scholar
• Nicolaides M, Charmandari E, Chrousos G, Kino T. Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions. Ann N Y Acad Sci. 2014;1318:71–80.
   PubMed Web of Science ®Google Scholar
• Stevens R, Brainard G, Blask D, Lockley S, Motta M. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin. 2014;64:207–218.
   PubMed Web of Science ®Google Scholar
• Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336:186–195.
   PubMed Web of Science ®Google Scholar
• Savard J, Morin C. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19:895–908.
   PubMed Web of Science ®Google Scholar
• Casault L, Savard J, Ivers H, Savard M, Simard S. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support Care Cancer. 2012;20:1203–1210.
   PubMed Web of Science ®Google Scholar
• Simeit R, Deck R, Conta-Marx B. Sleep management training for cancer patients with insomnia. Support Care Cancer. 2004;12:176–183.
   Web of Science ®Google Scholar
• Savard J, Ivers H, Savard MH, Morin CM. Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep. 2014;37(8):1305–1314.
   PubMed Web of Science ®Google Scholar
• Bakas T, McLennon S, Carpenter J, et al. Systematic review of health-related quality of life models. Health Qual Life Outcomes. 2012;10:134. doi:10.1186/1477-7525-10-134.
   PubMedGoogle Scholar
• Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37:336–342.
   PubMed Web of Science ®Google Scholar
• Ferrans CE. Differences in what quality-of-life instruments measure. J Natl Cancer Inst Monogr. 2007;(37):22–26.
   PubMedGoogle Scholar
• McCabe R, Grutsch J, Nutakki S, Braun D, Markman M. Can quality of life assessments differentiate heterogeneous cancer patients? PLoS One. 2014;9(6):e99445.
   Web of Science ®Google Scholar
• Grutsch J, Ferrans C, Wood P, et al. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011;11:193.
   PubMed Web of Science ®Google Scholar
• Badger T, Segrin C, Dorros S, Meek P, Lopez A. Depression and anxiety in women with breast cancer and their partners. Nurs Res. 2007;56(1):44–53.
   PubMed Web of Science ®Google Scholar
• Ng C, Boks M, Zaional N, De Wit N. The prevalence of pharmacotherapy of depression in cancer patients. J Affect Disord. 2011; 131:1–7.
   PubMed Web of Science ®Google Scholar
• Moussavi S, Chatterji S, Verdes E, Tandon A, Patel VU. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–858.
   PubMed Web of Science ®Google Scholar
• Stoudemire A, Thompson T. Medication non-compliance: systematic approaches to evaluation and intervention. Gen Hosp Psychiatry. 1983;5:233–239.
   PubMed Web of Science ®Google Scholar
• Montazeri A, Milroy R, Hole D, McEwen J, Gillis C. Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health. 1998;52:203–204.
   Web of Science ®Google Scholar
• McDaniel J, Musselman D, Porter M, Reed M, Nemeroff C. Depression in patients with cancer, diagnosis, biology and treatment. Arch Gen Psychiatry. 1995;52:89–99.
   PubMed Web of Science ®Google Scholar
• Massie M. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
   PubMedGoogle Scholar
• Navari R, Brenner M, Wilson M. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat. 2008;112:197–201.
   Web of Science ®Google Scholar
• Parker K, Bliwise D, Ribeiro M, et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol. 2008;26:2464–2472.
   PubMed Web of Science ®Google Scholar
• Du-Quiton J, Wood P, Burch J, et al. Actigraphy assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non small cell, lung cancer. Psycho-Oncology. 2010;19:180–189.
   PubMed Web of Science ®Google Scholar
• Sephton S, Sapolsky R, Kraemer H, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000.
   PubMed Web of Science ®Google Scholar
• Sephton S, Lush E, Dedert E, et al. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun. 2013;30:S162–S170.
   Web of Science ®Google Scholar
• Dugue P-A, Innominato P, Karaoue A, et al. Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int. 2014;31(8):891–900.
   Web of Science ®Google Scholar
• Palesh O, Aldrige-Gerry A, Zeitzer J, et al. Actigraphy measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep. 2014;37:837–842.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jin B, Ai F, et al. The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol. 2012;69:1213–1220.
   PubMed Web of Science ®Google Scholar
• Van Reeth O, Sturis J, Byrne MM, et al. Nocturnal exercise phase delays circadian rhythms of melatonin and thyrotropin secretion in normal men. Am J Physiol. 1994;266:E964–E974.
   PubMed Web of Science ®Google Scholar
• Schroder EA, Esser KA. Circadian rhythms, skeletal muscle molecular clocks, and exercise. Exerc Sport Sci Rev. 2013;41:224–229.
   PubMed Web of Science ®Google Scholar
• Baehr EK, Fogg LF, Eastman CI. Intermittent bright light and exercise to entrain human circadian rhythms to night work. Am J Physiol. 1999;277:R1598–R1604.
   PubMedGoogle Scholar
• Eastman CI, Hoese EK, Youngstedt SD, Liu L. Phase-shifting human circadian rhythms with exercise during the night shift. Physiol Behav. 1995;58(6):1287–1291.
   Web of Science ®Google Scholar
• Oike H, Oishi K, Kobori M. Nutrients, clock genes, and chrononutrition. Curr Nutr Rep. 2014;3:204–212. eCollection 2014. Review.
   PubMedGoogle Scholar
• Tanaka E, Yatsuya H, Uemura M, et al. Associations of protein, fat, and carbohydrate intakes with insomnia symptoms among middle-aged Japanese workers. J Epidemiol. 2013;23(2):132–138.
   PubMed Web of Science ®Google Scholar
• Grandner MA, Jackson N, Gerstner JR, Knutson KL. Dietary nutrients associated with short and long sleep duration. Data from a nationally representative sample. Appetite. 2013;64:71–80.
   PubMed Web of Science ®Google Scholar
• Afaghi A, O’Connor H, Chow CM. High-glycemic-index carbohydrate meals shorten sleep onset. Am J Clin Nutr. 2007;85(2):426–430. Erratum in: Am J Clin Nutr. 2007;86(3):809.
   PubMed Web of Science ®Google Scholar